[Present status and future perspective of RPGN in Japan].
Usui
Joichi
J
Yamagata
Kunihiro
K
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D001781:Blood Component Removal; D003520:Cyclophosphamide / Q000627:therapeutic use; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000145:classification* / Q000453:epidemiology* / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007564:Japan / Q000453:epidemiology; D008727:Methotrexate / Q000627:therapeutic use; D015337:Multicenter Studies as Topic; D011379:Prognosis; D012008:Recurrence; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires
D000305:Adrenal Cortex Hormones; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate